|
|
||||||||
The Journal of Immunology, Vol 148, Issue 10 3004-3011, Copyright © 1992 by American Association of Immunologists
ARTICLES |
DB Crumpacker, J Alexander, P Cresswell and VH Engelhard
Department of Microbiology, University of Virginia, Charlottesville 22908.
One model to explain the high frequency of alloreactive T cells proposes that allogeneic MHC molecules are recognized together with host cell-derived peptides. A model system was developed to investigate the relevance of this mechanism by expression of H-2Dd or H-2Ld in 174xCEM.T2 (T2) cells. This human cell line contains a mutation in its Ag-processing pathway that should restrict the association of endogenous peptides with cell surface class I molecules. CTL generated by stimulating C57BL/6 (H-2b) responder cells with H-2Dd or H-2Ld transfectants of the human B cell line C1R or the murine T cell lymphoma EL4 were assayed for their ability to recognize alloantigenic determinants on these transfectants. The major fraction of the H-2Dd- specific allogeneic CTL response, generated in a MLC or under clonal limiting dilution conditions, was composed of T cells that recognized H- 2Dd expressed on C1R or EL4 cells, but failed to recognize this molecule on T2 cells. Clonal analysis indicated that approximately one- third of these CTL recognized determinants that were unique to H-2Dd expressed on C1R stimulator cells whereas the remainder recognized determinants that were also found on EL4 transfectants. Less than 10% of H-2Dd-reactive CTL recognized the T2 transfectant, and these clones also killed C1R-Dd and EL4-Dd. This result suggests that the great majority of H-2Dd-specific alloreactive CTL recognize determinants that are formed by a complex of H-2Dd with endogenous peptides that are absent or significantly reduced in T2 cells. Based on recognition of human or murine transfectants, these CTL exhibit some level of specificity for the structure or composition of the bound peptides. Examination of allogeneic CTL specific for H-2Ld revealed populations similar to those described for H-2Dd. In addition, a major new population was present that recognized determinants shared between C1R- Ld and T2-Ld but not present on EL4-Ld. These results are consistent with the idea that the alloreactive response to H-2Ld is also largely dependent on the presence of bound peptide. However, they also may indicate that the H-2Ld molecule expressed on T2 cells is occupied by one or more peptides that are shared with other human, but not murine, cells. The significance of these results to current models of alloreactivity is discussed.
This article has been cited by other articles:
![]() |
C. Matte-Martone, J. Liu, D. Jain, J. McNiff, and W. D. Shlomchik CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL Blood, April 1, 2008; 111(7): 3884 - 3892. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Samino, D. Lopez, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val A Long N-terminal-extended Nested Set of Abundant and Antigenic Major Histocompatibility Complex Class I Natural Ligands from HIV Envelope Protein J. Biol. Chem., March 10, 2006; 281(10): 6358 - 6365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. E. Whitelegg, L. E. M. Oosten, S. Jordan, M. Kester, A. G. S. van Halteren, J. A. Madrigal, E. Goulmy, and L. D. Barber Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers J. Immunol., August 1, 2005; 175(3): 1706 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge J. Immunol., October 15, 2003; 171(8): 4028 - 4039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope J. Immunol., October 15, 2001; 167(8): 4238 - 4244. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rodriguez, M. K. Slifka, S. Harkins, and J. L. Whitton Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+ T-Cell Populations with Differing Cytolytic Activities J. Virol., August 15, 2001; 75(16): 7399 - 7409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moris, D. Wernet, S. Stevanovic, and H.-G. Rammensee The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205-anti-HLA-A*0201 pairings Int. Immunol., July 1, 2001; 13(7): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moris, V. Teichgraber, L. Gauthier, H.-J. Buhring, and H.-G. Rammensee Cutting Edge: Characterization of Allorestricted and Peptide-Selective Alloreactive T Cells Using HLA-Tetramer Selection J. Immunol., April 15, 2001; 166(8): 4818 - 4821. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rosa, R. Krishnan, S. Markel, J. P. Schneck, R. Houghten, C. Pinilla, and D. J. Diamond Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries Blood, March 15, 2001; 97(6): 1776 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsujimura, Y. Obata, S. Iwase, Y. Matsudaira, S. Ozeki, and T. Takahashi The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent Int. Immunol., September 1, 2000; 12(9): 1217 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Kovalik, N. Singh, S. K. Mendiratta, W. D. Martin, L. Ignatowicz, and L. Van Kaer The Alloreactive and Self-Restricted CD4+ T Cell Response Directed Against a Single MHC Class II/Peptide Combination J. Immunol., August 1, 2000; 165(3): 1285 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Zaia, J.G. P. Sissons, S. Riddell, D. J. Diamond, M.R. Wills, A.J. Carmichael, M.P. Weekes, M. Gandhi, C. La Rosa, M. Villacres, et al. Status of Cytomegalovirus Prevention and Treatment in 2000 Hematology, January 1, 2000; 2000(1): 339 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Peydro, A. Paradela, J. R. Lamas, and J. A. Lopez de Castro Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27 J. Immunol., December 1, 1999; 163(11): 6060 - 6064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Montoya and M. Del Val Intracellular Rate-Limiting Steps in MHC Class I Antigen Processing J. Immunol., August 15, 1999; 163(4): 1914 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mendiratta, J.-P. Kovalik, S. Hong, N. Singh, W. D. Martin, and L. Van Kaer Peptide dependency of alloreactive CD4+ T cell responses Int. Immunol., March 1, 1999; 11(3): 351 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Munz, R. Obst, W. Osen, S. Stevanovic, and H.-G. Rammensee Alloreactivity as a Source of High Avidity Peptide-Specific Human CTL J. Immunol., January 1, 1999; 162(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paradela, M. Garcia-Peydro, J. Vazquez, D. Rognan, and J. A. Lopez de Castro The Same Natural Ligand Is Involved in Allorecognition of Multiple HLA-B27 Subtypes by a Single T Cell Clone: Role of Peptide and the MHC Molecule in Alloreactivity J. Immunol., November 15, 1998; 161(10): 5481 - 5490. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Gil-Torregrosa, A. Raul Castano, and M. Del Val Major Histocompatibility Complex Class I Viral Antigen Processing in the Secretory Pathway Defined by the trans-Golgi Network Protease Furin J. Exp. Med., September 21, 1998; 188(6): 1105 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, K. D. Smith, and C. T. Lutz TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures J. Immunol., May 1, 1998; 160(9): 4305 - 4312. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard Class I-Restricted Alloreactive Cytotoxic T Lymphocytes Recognize a Complex Array of Specific MHC-Associated Peptides J. Immunol., February 1, 1998; 160(3): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Diamond, J. York, J.-Y. Sun, C. L. Wright, and S. J. Forman Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection Blood, September 1, 1997; 90(5): 1751 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Smith, A. Brunmark, M. R. Jackson, and T. A. Potter Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL) J. Exp. Med., March 17, 1997; 185(6): 1023 - 1034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |